Surgical Treatment in Active Infective Endocarditis: Results of a Four-Year Experience
Author(s) -
Carlo Rostagno,
Enrico Carone,
Alessandra Rossi,
Gian Franco Gensini,
Pierluigi Stefàno
Publication year - 2011
Publication title -
isrn cardiology
Language(s) - English
Resource type - Journals
eISSN - 2090-5599
pISSN - 2090-5580
DOI - 10.5402/2011/492543
Subject(s) - medicine , endocarditis , infective endocarditis , surgery , tricuspid valve , mortality rate
Background . Aim of present investigation was to analyze survival and recurrence rate in patients with active endocarditis referred to our centre for surgical treatment. Methods . 80 consecutive patients with active infective endocarditis (52 males, 28 females, mean age 59.2 years) were referred to our institution for surgical treatment. 78 patients underwent surgery, and 2 patients died before intervention. Results . Fifty patients had native valve endocarditis, 30 prosthetic valve involvement. Hospital mortality has been 10.2%. Three discharged patients (4.9%) died at an average 18-month followup. Endocarditis recurred in 4 (2 being S. aureus prosthetic tricuspid endocarditis in drug addicts). All patients who underwent valve repair or homograft implant were alive and free of recurrence. Conclusions . Our results suggest that with proper surgical treatment patients with active endocarditis discharged alive from hospital have a survival >90% at 18 months with a low recurrence rate.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom